PREDICT Study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology
Researchers at EF Clif identify three different clinical courses for the first time, in patients with acute decompensated cirrhosis without acute-on-chronic liver failure (ACLF). July 14, 2020 – A clinical study led…
Journal of Hepatology ranking climbs, remaining best journal on liver disease
ClarivateTM Analytics released the 2020 update of its Journal Citation Reports©, including the much anticipated 2019 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2019…
Blood tests can predict the risk of liver cirrhosis
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published…
Digital ILC 2020 – Meet the experts
This is the ideal opportunity for you to learn from some of the biggest names in hepatology and meet them in an engaging & interactive setting!
Maternal obesity increases the chance of liver cancer in offspring for generations
Scientists have identified a microRNA in obese mouse mothers that may increase the odds of liver cancer in their offspring throughout multiple generations, report scientists in the Journal of Hepatology. Amsterdam, June…
Explore the Metabolism, Alcohol and Toxicity track programme for The Digital ILC 2020
EASL has been actively working to beat liver disease, including NAFLD & NASH, through its schools and key event, the NAFLD Summit. EASL has also developed a Policy Statement on the measures…
